Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Sana Biotechnology, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 154
- +23 vs. Q4 2023
- Shares held
- 146.3M
- +21.8M (+17.5%) vs. Q4 2023
- Total value
- $1.46B
- +$954.8M (+187.9%) vs. Q4 2023
- New holders
- 38
- 46 more added
- Sold out
- 15
- 40 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SANA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $644.7M |
| Q1 2026 | 203 | $473.1M |
| Q4 2025 | 203 | $648.8M |
| Q3 2025 | 178 | $581.8M |
| Q2 2025 | 155 | $396.9M |
| Q1 2025 | 161 | $250.6M |
| Q4 2024 | 164 | $257.4M |
| Q3 2024 | 155 | $638.8M |
| Q2 2024 | 148 | $810.3M |
| Q1 2024 | 154 | $1.46B |
| Q4 2023 | 132 | $508.1M |
| Q3 2023 | 136 | $493.5M |
| Q2 2023 | 123 | $804.1M |
| Q1 2023 | 120 | $427.4M |
| Q4 2022 | 120 | $507.0M |
| Q3 2022 | 125 | $769.7M |
| Q2 2022 | 116 | $807.5M |
| Q1 2022 | 117 | $985.8M |
| Q4 2021 | 105 | $1.73B |
| Q3 2021 | 88 | $2.48B |
| Q2 2021 | 80 | $1.93B |
| Q1 2021 | 78 | $3.10B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Sana Biotechnology, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 125,325 | $1.25M | 0.00% | −1,270−1.0% | Reduced |
| Susquehanna Fundamental Investments, LLC | 134,309 | $1.34M | 0.06% | +134,309 | New |
| Jane Street Group, LLC | 146,456 | $1.46M | 0.00% | +125,942+613.9% | Added |
| AQR Capital Management LLC | 155,792 | $1.56M | 0.00% | +131,475+540.7% | Added |
| Regents of the University of California | 156,254 | $1.56M | 0.45% | 00.0% | Unchanged |
| Rhumbline Advisers | 156,847 | $1.57M | 0.00% | +4,863+3.2% | Added |
| Renaissance Technologies LLC | 172,900 | $1.73M | 0.00% | −122,200−41.4% | Reduced |
| Swiss National Bank | 194,100 | $1.94M | 0.00% | 00.0% | Unchanged |
| Zimmer Partners, LP | 202,500 | $2.02M | 0.04% | +202,500 | New |
| Massachusetts Financial Services Co | 238,831 | $2.39M | 0.00% | −814,499−77.3% | Reduced |
| Norges Bank | 249,621 | $2.50M | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 288,874 | $2.89M | 0.00% | +25,397+9.6% | Added |
| CI Private Wealth, LLC | 337,463 | $3.37M | 0.01% | −75,897−18.4% | Reduced |
| Bank of New York Mellon Corp | 341,321 | $3.41M | 0.00% | −21,691−6.0% | Reduced |
| Octagon Capital Advisors LP | 360,800 | $3.61M | 0.44% | +360,800 | New |
| UBS Group AG | 373,727 | $3.74M | 0.00% | +66,307+21.6% | Added |
| Verition Fund Management LLC | 384,279 | $3.84M | 0.04% | −100,656−20.8% | Reduced |
| Capital International Investors | 432,071 | $4.32M | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 435,040 | $4.35M | 0.00% | +222,886+105.1% | Added |
| Citigroup Inc | 469,670 | $4.70M | 0.01% | +279,770+147.3% | Added |
| Rafferty Asset Management, LLC | 495,932 | $4.96M | 0.02% | +58,318+13.3% | Added |
| TD Asset Management Inc | 521,112 | $5.21M | 0.00% | +158,460+43.7% | Added |
| Dimensional Fund Advisors LP | 525,007 | $5.25M | 0.00% | +468,720+832.7% | Added |
| Bank of America Corp | 548,027 | $5.48M | 0.00% | +66,237+13.7% | Added |
| Nuveen Asset Management, LLC | 554,588 | $5.55M | 0.00% | −173,446−23.8% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 583,489 | $5.83M | 0.03% | +355,489+155.9% | Added |
| PFM Health Sciences, LP | 675,000 | $6.75M | 0.34% | −1,208,337−64.2% | Reduced |
| ArrowMark Colorado Holdings LLC | 685,125 | $6.85M | 0.08% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 823,510 | $8.24M | 0.00% | +74,675+10.0% | Added |
| Omega Fund Management, LLC | 843,750 | $8.44M | 5.44% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 852,776 | $8.53M | 0.00% | +22,484+2.7% | Added |
| Northern Trust Corp | 866,141 | $8.66M | 0.00% | −20,832−2.3% | Reduced |
| Marshall Wace, LLP | 869,985 | $8.70M | 0.01% | +869,985 | New |
| Woodline Partners LP | 899,050 | $8.99M | 0.08% | +214,856+31.4% | Added |
| Integral Health Asset Management, LLC | 980,000 | $9.80M | 0.96% | +980,000 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 984,000 | $9.84M | 0.26% | +984,000 | New |
| JPMorgan Chase & Co | 1,105,487 | $11.1M | 0.00% | −85,147−7.2% | Reduced |
| Morgan Stanley | 1,489,680 | $14.9M | 0.00% | +756,278+103.1% | Added |
| Boxer Capital, LLC | 1,545,000 | $15.4M | 0.76% | +1,545,000 | New |
| Citadel Advisors LLC | 1,887,156 | $18.9M | 0.02% | +1,847,280+4,632.6% | Added |
| Baker Bros. Advisors LP | 2,380,949 | $23.8M | 0.30% | +380,949+19.0% | Added |
| Geode Capital Management, LLC | 2,416,518 | $24.2M | 0.00% | +162,682+7.2% | Added |
| Alphabet Inc. | 2,812,500 | $28.1M | 1.12% | 00.0% | Unchanged |
| Crestline Management, LP | 3,365,624 | $33.7M | 3.19% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,695,459 | $37.0M | 0.00% | +101,434+2.8% | Added |
| T. Rowe Price Investment Management, Inc. | 4,801,847 | $48.0M | 0.03% | +4,801,847 | New |
| Capital World Investors | 5,449,035 | $54.5M | 0.01% | +3,917,728+255.8% | Added |
| State Street Corp | 6,370,165 | $63.7M | 0.00% | +461,478+7.8% | Added |
| BlackRock Inc. | 9,046,144 | $90.5M | 0.00% | +576,922+6.8% | Added |
| Canada Pension Plan Investment Board | 10,175,000 | $101.8M | 0.11% | 00.0% | Unchanged |
| Baillie Gifford & Co | 10,656,279 | $106.6M | 0.08% | +506,262+5.0% | Added |
| Vanguard Group Inc | 12,155,173 | $121.6M | 0.00% | +2,358,089+24.1% | Added |
| FMR LLC | 22,042,537 | $220.4M | 0.01% | +6,291,246+39.9% | Added |
| Flagship Pioneering Inc. | 25,001,856 | $250.0M | 16.40% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,606,056−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −254,403−100.0% | Sold out |
| Mitsubishi UFJ Trust & Banking Corp | 0 | $0 | 0.00% | −206,260−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −177,000−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −117,694−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −105,612−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −40,179−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,282−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −29,800−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −27,061−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,400−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,527−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −12,530−100.0% | Sold out |
| Bartlett & Co. LLC | – | – | – | – | Not filed |